# Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

> **NCT00002139** · PHASE1 · COMPLETED · sponsor: **Pfizer**

## Conditions studied

- Bacterial Infections
- HIV Infections

## Interventions

- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00002139
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002139, "Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT00002139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*